Serving To Educate Primary Care Clinicians On Metabolic Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Prescriber's Letter April 2015

Prescriber’s Letter addresses the drug therapy issues facing medical professionals. For example:

  • What is the concentrated U-300 insulin, Toujeo (insulin glargine)?
  • How is Toujeo different than other long-acting basal insulins?
  • Will Toujeo be an alternative to Humulin R U-500 concentrated insulin?
  • When should Toujeo be used?
  • How should patients switch from other basal insulins to Toujeo, and vice versa?
  • How much will Toujeo cost?
  • How is Toujeo supplied?
  • are dose conversions needed with Toujeo like we often see with U-500?


 If you would like to access this month's full sample article on LEVOTHYROXINE from Prescriber's letter, please click here

For the most recent full article AND to access all of the benefits of Prescriber's Letter subscribe to an option below:

Prescriber's Letter offers PCMG Members a 10% discount at two subscription levels:

The Gold Subscription is $129 and includes CME

The Platinum Subscription is $189 and provides enhanced CME and Live Webinar access 

Enter Discount Code PCMG15 when ordering either subscription HERE